13 Update of cytogenetic risk factors in MDS (Part II): a strategy to incorporate fluorescence in situ hybridization (FISH) and “FISH on a Chip” (aCGH) results in future clinical trials for the myelodysplastic syndromes (MDS)
Autor: | Slovak, M.L., Dewald, G. |
---|---|
Zdroj: | In Leukemia Research 2009 33 Supplement 1:S10-S10 |
Databáze: | ScienceDirect |
Externí odkaz: |